Dexcom (DXCM) is a publicly traded Healthcare sector company. As of August 15, 2026, DXCM trades at $89.26 with a market cap of $34.26B and a P/E ratio of 34.70. DXCM moved -1.84% today. Year to date, DXCM is +34.88%; over the trailing twelve months it is +12.24%. Its 52-week range spans $54.11 to $93.25. Analyst consensus is strong buy with an average price target of $90.52. Rallies surfaces DXCM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dexcom (DXCM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DXCM moved -1.84% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $89.26 |
| Market Cap | $34.26B |
| P/E Ratio | 34.70 |
| EPS | $2.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $93.25 |
| 52-Week Low | $54.11 |
| Volume | 3.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.97B |
| Net Income | $999.70M |
| Gross Margin | 62.47% |
23 analysts cover DXCM: 0 strong buy, 21 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $90.52.